Asian Liver Center’s community research aims to provide evidence based information that would be of value to policy makers in developing effective national strategies to prevent chronic hepatitis B and liver cancer. For more, see Recent Publications.
Toy M, Hutton DW, So S. (2018) Population health and economic impacts of reaching chronic hepatitis B diagnosis and treatment targets in the US. Health Affairs 37(7):1033-1040.
Ispas S, So S, Toy M. Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States. J Community Health. 2018 Dec 11. doi: 10.1007/s10900-018-00604-7. [Epub ahead of print]
Han SS, Kelly SP, Li Y, Yang B, Nguyen M, So S, Rosenberg PS, Hsing AW. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. J Natl Cancer Inst. 2018 Dec 13. doi: 10.1093/jnci/djy180. [Epub ahead of print]
Toy M, Wei B, Virdi TS, Le A, Trinh H, Li J, Zhang J, Hsing AW, So SK, Nguyen MH. Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. Hepatol Med Policy. 2018 Jun 5;3:6. doi: 10.1186/s41124-018-0034-7. eCollection 2018.
Yang B, Liu JB, So SK, Han SS, Wang SS, Hertz A, Shariff-Marco S, Lin Gomez S, Rosenberg PS, Nguyen MH, Hsing AW. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. Cancer. 2018 Sep 1;124(17):3551-3559. doi: 10.1002/cncr.31598. Epub 2018 Aug 16.
Fitzmaurice C, Allen C, Barber RM et al. (2017) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study JAMA Oncology 2017; 3 (4): 524-548. 10.1001/jamaoncol.2016.5688.
A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Gillian J. Buckley and Brian L. Strom, Editors; Committee on a National Strategy for the Elimination of Hepatitis B and C; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering and Medicine. Washington, DC. 2017.
National Academies of Sciences, Engineering and Medicine. 2016. Eliminating the public health problem of hepatitis B and C in the United States: Phase one report. Washington, DC: The National Academies Press. doi:10.17226/23407.
Wang J, Feng Q, Tam A, Sun T, Zhou P, So S. 2016. Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China. BMC Med Educ. Mar 8;16:81. doi: 10.1186/s12909-016-0608-2.
Stanaway JD, Flaxman AD, Naghavi M et al. 2016. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 388(10049): 1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.